A key Republican senator has criticised the U.S. Food and Drug Administration (FDA) for moving too slowly on tobacco regulation during a hearing on the agency’s priorities.
Sign up to access our business and regulatory briefings and get the most updated news, insights and our expert analysis to keep you on top of worldwide industry trends.